InvestorsHub Logo
Followers 0
Posts 33
Boards Moderated 0
Alias Born 08/05/2019

Re: Gladys Thong post# 7354

Wednesday, 12/25/2019 11:42:24 PM

Wednesday, December 25, 2019 11:42:24 PM

Post# of 9238
This, as most articles of this nature completely ignore the expansion into the American market.

All of these points are addressed in the most recent earnings report including PEACE+ CBD tincture products being introduced through a test market of approximately 1,000 retail stores in the U.S. and expanding to 100,000 stores plus.

From the earnings report:

PEACE+, it's something that we plan to expand gradually throughout the year as we get market learnings and see expansion opportunities. But what we're really testing for and hoping to learn are all the facts of the value equation for, specifically here for the tincture category, the consumer preference, the consumer insights, pricing, merchandising, insights from the retail partners, flavors. And it's important for us to get that in the 1,000 stores because as we look at expanding, when you go from 1,000 to 10,000 to 50,000 to 100,000,....

Canopy has a price spread on there products from $14.99 to $64.99.

Canopy Growth—the world’s largest legal cannabis company, worth about $6.4 billion—quietly launched its new CBD brand, called First & Free. On its website, the brand is selling capsules and tinctures for prices ranging from $14.99 to $64.99 to customers in 31 US states


Doing the math for CRON for one sale a day per store @ $14.99 X 100,000 stores X 365 days is $547 million revenue per year. Increase the store count to 200,000 and multiple products and you are looking at a $1 billion dollar plus revenue per year company very quickly!

If you haven't already, I would suggest a thorough reading of the latest earnings report. It is very eye opening in regards to the potential revenue and earnings of CRON in the near future.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CRON News